Sanofi Epilepsy Drug Linked to Birth Defects

Apr 20, 2017

Reuters

France's drug regulator said up to 4,100 children in France suffered major malformations in the womb after their mothers took valproate to treat epilepsy and bipolar disorders between 1967 and 2016, according to a Reuters article.

Valproate, made in France by Sanofi under the brand Depakine for epilepsy and Depakote and Depamide for bipolar disorders, is also said to cause slow neurological development, ANSM added.

Sanofi reportedly said it had been transparent with authorities and that it tried to keep doctors and patients informed of medical information.

Read the Reuters story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments